Winton Capital »

Terns Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $493k 66k 7.51

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ge Vernova (GEV)
Select Sector Spdr Tr Sbi Materials (XLB)
Devon Energy Corporation (DVN)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Fastenal Company (FAST)
Incyte Corporation (INCY)
Masco Corporation (MAS)
Five Below (FIVE)
Johnson Ctls Intl SHS (JCI)

View all positions for Winton Capital

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Deep Track Capital
Morgan Stanley
Vivo Capital
Commodore Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Candriam Luxembourg S.C.A.
Acorn Capital Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Terns Pharmaceuticals